Clover Biopharmaceuticals gets a $2 billion valuation on the hopes of a Delta-effective vaccine Read More
Related Articles
The challenge of investing in innovation
Here’s why more than 40% of businesses have increased their innovation budgets recently. Read More
The land of cheap mortgages just went to zero
The country with the longest history of negative central bank rates is offering homeowners 20-year loans at a fixed interest rate of zero. Customers at the Danish home-finance unit of Nordea Bank Abp can, as of Tuesday, get the mortgages, which will carry a lower coupon than benchmark U.S. 10-year Treasuries. Denmark stands out in […]
Vaccines Can Not lift a Set day for International markets
Superior day, Bull Sheeters. That can be Fortune fund reporter Rey Mashayekhi, filling in this week to get Bernhard using a distinctive PM variant of this newsletter. It turned out to be a controlled day for its worldwide markets. Wednesday morning’s information that the U.K. has since accepted that the Pfizer/BioNTech COVID-19 vaccine for supply […]